A practical approach to the use of intravenous immunoglobulin in neurological disease.
Intravenous immunoglobulin is now used in a wide range of neurological conditions. However, side effects are relatively common, treatment is expensive and sustained benefit unusual without repeated administration. This article aims to provide clinicians with an overview of the potential benefits and drawbacks of intravenous immunoglobulin in neurological practice and concludes with suggested guidelines for its use in adults.
Wills
A J
AJ
The National Hospital for Neurology and Neurosurgery, London, UK.
Unsworth
D J
DJ
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D001327:Autoimmune Diseases / Q000628:therapy; D003711:Demyelinating Diseases / Q000628:therapy; D016756:Immunoglobulins, Intravenous / Q000009:adverse effects / Q000627:therapeutic use*; D009422:Nervous System Diseases / Q000628:therapy*; D011129:Polyradiculoneuropathy / Q000628:therapy; D017410:Practice Guidelines as Topic; D012307:Risk Factors
D000276:Adjuvants, Immunologic; D016756:Immunoglobulins, Intravenous